We are faced with a global pandemic of tuberculosis and new tools to control this disease are needed urgently. We believe that new and old optimized drugs are central to any control strategy and the fastest route to tuberculosis elimination.
Latest news
SimpliciTB General Assembly
The first formal meeting of SimpliciTB General Assembly (GA) took place on the 25th of July. We had an excellent representation of the collaborating groups with 20 attendees from 9 countries. The Executive Group (EG) has been established with colleagues from South Africa, Tanzania, and our new partners from Uganda, Mozambique, Malawi and Gabon joining the group. A…
PanACEA General Assembly
On the 1st of July the PanACEA General Assembly met by teleconference for its quarterly gathering. The program of the project is progressing as the preparations for the next trials are ongoing and the Operational Teams are meeting on a regular basis. The Expertise Cores are involved as well, rolling out the MBL assay, building…
PanACEA and TB Alliance get SimpliciTB grant
SimpliciTB is a multi-centre phase 3 clinical trial evaluating a new shorter drug regimen (all-oral BPaMZ) in drug susceptible and resistant pulmonary tuberculosis across 4 continents led by TB Alliance. The trial started in 2018 and the European and Developing Countries Clinical Trials Partnership (EDCTP) has recently awarded 12 million euro for the execution of the…
Annual Meeting 2019
On 19 and 20 March 2019 hosting partner Instituto Nacional de Saúde welcomed the General Assembly to Maputo, Mozambique, for the second PanACEA II Annual Meeting. Highlights of the second year of the PanACEA II programme were the completion of the HR1 trial, start of the postgraduate programme, site assessment visits and capacity development activities (e.g.…
General Assembly teleconference December
In the quarterly teleconference on 10 December 2018 the PanACEA partners assembled to discuss the progress of the projects program. We looked back to 2018 as a year in which we ended our first trial. We are ready to start 2019, when our other trials are scheduled to start. The General Assembly meets again, face…